Professional Documents
Culture Documents
GASTROINTESTIN
AL BLEEDING
CASE PRESENTATION
BSN 3-1
GROUP MEMBERS
Padiernos, Astrid Jody
Pangilinan, Riz-Ann
Parocha, Lanrose
Romero, Roman Tristan Glenn
Tumibay, Noreen Lianne
Vitales, Jasmin Mae
GENERAL OBJECTIVE
After the case presentation, the patient, patient’s family members,
health professionals, and nursing students will be able to acquire
knowledge about the patient’s condition, familiarize themselves with
the clinical manifestations, etiology, and upper gastrointestinal bleeding
complications. Additionally, the nursing students will develop effective
treatment plans and nursing interventions for patients having this kind
of disease.
SPECIFIC OBJECTIVES
At the end of the presentation, the nursing students must be able to
:
1. Present a thorough general assessment which includes physical
examination and family history taking.
2. Illustrate the pathophysiology and physiologic response of the
body.
SPECIFIC OBJECTIVES
3. Recognize common causes and underlying disease processes
of upper gastrointestinal bleeding.
4. Understand and discuss upper gastrointestinal bleeding
management, including the medical and pharmacological
approach and the possible side effects of the drugs.
SPECIFIC OBJECTIVES
IV. Esophagitis
DEFINITION OF CASE
V. Angiodysplasia
DEFINITION OF CASE
V. Angiodysplasia
VI. Colitis
DEFINITION OF CASE
V. Angiodysplasia
VI. Colitis
VII. Gastritis
DEFINITION OF CASE
Complications:
A gastrointestinal bleed can cause:
Shock
Anemia
Death
PATIENT’S DATA
BIOGRAPHY DATA:
Patient: Pt. X
Sex: Male
Age: 37 years old
Address: Sta Rosa, Nueva Ecija
Civil Status: Single
Nationality: Filipino
Religion: Roman Catholic
PATIENT’S DATA
ADMITTING HISTORY:
Admission Date: March 22, 2021
Time: 1:20 PM
Diagnosis: Upper Gastrointestinal
Bleeding (UGIB); t/c Anemia
CHIEF COMPLAINT:
Patient experienced vomiting of blood and
had a passage of black stool
PATIENT’S DATA
NEUROLOGIC ASSESSMENT:
LOC: GCS 15
Pupils: 3(mm)
Deep tendon reflexes: normal
PHYSICAL EXAMINATION:
Vital Signs (Day 1):
Temp: 36.5 C
PR: 65 bpm
RR: 18 cpm
BP: 100/70 mmHg
PHYSICAL ASSESSMENT
BODY PARTS NORMAL FINDINGS ACTUAL FINDINGS ANALYSIS/RESULT
Skull Rounded, smooth skull Head Size: normocephalic Normal findings.
contour, absence of nodules Shape: round,
and masses. Normal head symmetrical
circumference for 8-month-
old is 44.5 cm.
Hair Evenly distributed hair, thick Evenly distributed, black Normal findings
hair, no signs of infection, in color, (-) abnormalities
and no presence of dandruff,
silky and resilient hair.
PHYSICAL ASSESSMENT
Face Has symmetric facial features and Symmetrical / no facial Normal findings.
movements. asymmetry
Eyes Eyebrows and eyelashes are Anicteric sclera Pale conjunctiva is a sign that
evenly distributing. The eyelids Pupil response: PERRLA the patient is dehydrated
have no discharge and no (Pupils are equal, round, related to blood loss when
discoloration of pupils. Pupils are and reactive to light vomiting
black in color, round, equal in size and accommodation)
normally 3-7 mm in diameter, Pale conjunctiva
reactive to light and
accommodation; conjunctiva pink
in color, the sclera is white in color.
GASTROINTESTINAL TRACT
STOMACH
DUODENUM
ANATOMY & PHYSIOLOGY
Lower Gastrointestinal Tract
• The contents of the small intestine
empty into the large intestine, which
is also called the colon. While food
travels through the colon, the water
and salts are absorbed.
• Once the nutrients are removed from
the food, the remaining materials
become stool – which moves into the
rectum to be expelled from the body
as waste.
LARGE SMALL
INTESTINE INTESTINE
ANUS
pathophysiology
H. Pylori (gram
NSAIDs Stress induced
negative bacteria)
Toxin
release Ischemic
COX-1 Toxicity to
inhibition Gastric
Inflammatory epithelial In ICU
response cells setting
Decreased
prostaglandins
Inhibition
of H+
detection
in gastric H+
antrum production,
gastric
H+ over- mucous
secretion production
Mucosal Injurious
Gastroprotective Factors
Substances
Gastroprotective Factors: Mucosal Injurious
• Mucous Substances
• Blood Flow • Acid
• Epithelial Cells • Toxins
Erosion of Mucosa
• Prostaglandins
PEPTIC ULCER
(Erosion into blood
vessels)
COFFEE-
MELENA GROUND
(black, tarry, EMESIS
foul-smelling
stool)
H. pylori
Decreased in
Increased acid
Alcohol and production of Reduced
Smoking
secretion with
Bicarbonate Blood Flow
back diffusion Buffer
NSAIDs
MELENA
EPIGASTRIC NAUSEA & HEMATEMESIS (black, tarry,
PAIN VOMITING (Vomiting of blood) foul-smelling
stool)
SIGNS AND SYMPTOMS
● black or tarry stool
SIGNS AND SYMPTOMS
● black or tarry stool
● Vomitus of bright red blood
SIGNS AND SYMPTOMS
● black or tarry stool
● Vomitus of bright red blood
● Paleness
● Weakness
LABORATORY STUDY
Gastric Lavage
DIAGNOSTIC EXAMINATIONS
Gastric Lavage
Endoscopy
DIAGNOSTIC EXAMINATIONS
Gastric Lavage
Endoscopy
Abdominal CT Scan
VIII. MEDICAL MANAGEMENT
● Blood transfusions
● Upper endoscopy
● Administer antibiotics as prescribed
NURSING CARE
PLAN
X. NURSING CARE PLAN
X. NURSING CARE PLAN
X. NURSING CARE PLAN
DRUG STUDY
XI. DRUG STUDY
Generic Name Name of Action/Contraindications/Si Nursing
Medication
Dosage
de effects Implications/Nursing
(Brand Name) Responsibilities
Metoclopramide Copra, Emex, 10mg-3x a day Action: -Assess for extrapyramidal
Maxeran, symptoms and tardive
Anti cholinergic, Anti emetic
dyskinesia(more likely in older
maxolon,
Contraindications: patients)
Reglan
Patient with gastrointestinal -Assess for gastrointestinal
obstruction, perforation, or complaints such as nausea,
haemorrhage, phaechromycytoma, vomiting and constipation
breastfeeding
-For oral administration, better
Side Effects: absorption allow 30 min to one
hour before eating
Extrapyrimidal effects,
Hyperprolactinemia, Tardive -Instruct the patient to avoid
dyskinesia, drowsiness, alcohol or other CNS
restlessness, diarrhea depressants
1.Activities:
Rest as directed.
Ask when you can return to your
usual activities, such as work.
DISCHARGE PLANNING
3.Prevention:
• Medicines
Take all medicines for these conditions as directed.
Ask your healthcare provider if it is safe for you to take
NSAIDs.
3.Prevention:
• Do not smoke
Nicotine and other chemicals in cigarettes and cigars
can increase your risk for ulcers.
• Asepsis
If you have had surgery, to care for your surgical
wound, wash your hands before changing the dressing
and after disposing of the dressing.
DISCHARGE PLANNING
4.Follow-up care is a key part of your treatment and safety:
Be sure to make and go to all appointments.
They should have prompt follow-up identified for
monitoring of their hemoglobin and referral to
gastroenterology for endoscopy or colonoscopy as
appropriate.
REFERENCES
Varma, M. (2018, November 19). Upper Gastrointestinal Bleeding Imaging.
Emedicine.Medscape. https://emedicine.medscape.com/article/417980-overview
Gastrointestinal (GI) Bleeding. (n.d.). National Institute of Diabetes and Digestive and Kidney
information/digestive-diseases/gastrointestinal-bleeding/definition-facts
Ahmed, A., Stanley, A.J. Acute Upper Gastrointestinal Bleeding in the Elderly. Drugs Aging 29, 933–940 (2012).
https://doi.org/10.1007/s40266-012-0020-5
Gastrointestinal Bleeding. (n.d.). Drugs.Com. Retrieved March 28, 2021, from
https://www.drugs.com/cg/gastrointestinal-bleeding-discharge-care.html#:~:text=A%20special
%20diet%20can%20help,heartburn%2C%20nausea%2C%20or%20diarrhea
REFERENCES
Healthwise Staff. (2019, June 26). Upper Gastrointestinal Bleeding: Care
Instructions. MyHealth.Alberta.Ca.
https://myhealth.alberta.ca/Health/aftercareinformation/pages/conditions.aspx?hwid=
zp4085
Britannica, T. Editors of Encyclopaedia (2019, April 10). Gastrointestinal tract.
Encyclopedia Britannica. https://www.britannica.com/science/gastrointestinal-tract
https://www.niddk.nih.gov/health-information/digestive-diseases/gastrointestinal-blee
ding/diagnosis
REFERENCES
Wayne, G. (2020, September 7). Fluid Volume Deficit (Dehydration) Nursing Care
https://www.scribd.com/doc/61445304/Ncp-Activity-Intolerance-Related-to-Decreased-i
n-Oxygen-Supply
Omeprazole (Rx, OTC). (n.d.). Medscape. Retrieved March 25, 2021, from
https://reference.medscape.com/drug/prilosec-omeprazole-341997
END OF
PRESENTATION
THANK YOU!